Literature DB >> 12019217

The mitochondrial protein frataxin prevents nuclear damage.

Gopalakrishnan Karthikeyan1, L Kevin Lewis, Michael A Resnick.   

Abstract

The mitochondrial protein frataxin helps maintain appropriate iron levels in the mitochondria of yeast and humans. A deficiency of this protein in humans causes Friedreich's ataxia, while its complete absence in yeast (Delta yfh1 mutant) results in loss of mitochondrial DNA, apparently due to radicals generated by excess iron. We found that the absence of frataxin in yeast also leads to nuclear damage, as evidenced by inducibility of a nuclear DNA damage reporter, increased chromosomal instability including recombination and mutation, and greater sensitivity to DNA-damaging agents, as well as slow growth. Addition of a human frataxin mutant did not prevent nuclear damage, although it partially complemented the Delta yfh1 mutant in preventing mitochondrial DNA loss. The effects in Delta yfh1 mutants result from reactive oxygen species (ROS), since (i) Delta yfh1 cells produce more hydrogen peroxide, (ii) the effects are alleviated by a radical scavenger and (iii) the glutathione peroxidase gene prevents an increase in mutation rates. Thus, the frataxin protein is concluded to have a protective role for the nucleus as well as the mitochondria.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12019217     DOI: 10.1093/hmg/11.11.1351

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  34 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

Review 2.  Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.

Authors:  Ngolela E Babady; Nadege Carelle; Robert D Wells; Tracey A Rouault; Michio Hirano; David R Lynch; Martin B Delatycki; Robert B Wilson; Grazia Isaya; Hélène Puccio
Journal:  Mol Genet Metab       Date:  2007-06-26       Impact factor: 4.797

3.  Association between trinucleotide CAG repeats of the DNA polymerase gene (POLG) with age of onset of Iranian Friedreich's ataxia patients.

Authors:  Mohammad Mehdi Heidari; Massoud Houshmand; Saman Hosseinkhani; Shahriar Nafissi; Barbara Scheiber-Mojdehkar; Mehri Khatami
Journal:  Neurol Sci       Date:  2008-11-28       Impact factor: 3.307

4.  Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect.

Authors:  Joshua R Veatch; Michael A McMurray; Zara W Nelson; Daniel E Gottschling
Journal:  Cell       Date:  2009-06-26       Impact factor: 41.582

Review 5.  The structure and function of frataxin.

Authors:  Krisztina Z Bencze; Kalyan C Kondapalli; Jeremy D Cook; Stephen McMahon; César Millán-Pacheco; Nina Pastor; Timothy L Stemmler
Journal:  Crit Rev Biochem Mol Biol       Date:  2006 Sep-Oct       Impact factor: 8.250

Review 6.  Genetic instability in budding and fission yeast-sources and mechanisms.

Authors:  Adrianna Skoneczna; Aneta Kaniak; Marek Skoneczny
Journal:  FEMS Microbiol Rev       Date:  2015-06-24       Impact factor: 16.408

7.  Genome-wide screen for genes with effects on distinct iron uptake activities in Saccharomyces cerevisiae.

Authors:  Emmanuel Lesuisse; Simon A B Knight; Maïté Courel; Renata Santos; Jean-Michel Camadro; Andrew Dancis
Journal:  Genetics       Date:  2004-10-16       Impact factor: 4.562

8.  Ferroportin and erythroid cells: an update.

Authors:  Luciano Cianetti; Marco Gabbianelli; Nadia Maria Sposi
Journal:  Adv Hematol       Date:  2010-08-11

9.  The ferroxidase activity of yeast frataxin.

Authors:  Sungjo Park; Oleksandr Gakh; Steven M Mooney; Grazia Isaya
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

10.  Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae.

Authors:  Anne Karin Rasmussen; Aditi Chatterjee; Lene Juel Rasmussen; Keshav K Singh
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.